Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05838027 · ClinicalTrials.gov registry record · NA

Pilot Guaranteed Income Study, Philadelphia, April 2023

A NA study of Cardiovascular Diseases, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05838027: Completed NA study of Cardiovascular Diseases, sponsored by University of Pennsylvania.

NCT05838027 is a NA study of Cardiovascular Diseases that has completed, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05838027, a NA study of Cardiovascular Diseases, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot clinical trial is to learn about the effects of a short-term unconditional cash transfer (UCT) in people living with poverty and chronic disease (either prediabetes/diabetes or hypertension). The main questions it aims to answer are: * How feasible and acceptable is the intervention? * How are key health behaviors and outcomes affected by the intervention? * What are reasonable effect sizes to expect in a larger trial? Participants will complete surveys and health measurements at two timepoints 3 months apart. Half of the participants will be randomly assigned to the treatment where they will receive a UCT of $1000 over 4 months. Researchers will compare the treatment group to the control group to see if there are improvements in health risk factors directly related to insufficient resources (food and utility security, stress-levels, mental bandwidth), financial outcomes, and health behaviors.

Primary Outcome

Change from baseline in food security in the last 30 days as measured by the US Department of Agriculture food security scale. Outcome is 3 ordered categories: high or marginal food security, low food security, very low food security.

Conditions Studied

Interventions

  • BEHAVIORAL Cash Transfer

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-04-04
Est. Completion 2023-10-20
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT05838027 record still lists

NCT05838027 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Cash Transfer is the first listed.

NCT05838027 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05838027 about?

NCT05838027 is a clinical study titled "Pilot Guaranteed Income Study, Philadelphia, April 2023". The goal of this pilot clinical trial is to learn about the effects of a short-term unconditional cash transfer (UCT) in people living with poverty and chronic disease (either prediabetes/diabetes or hypertension). The main questions it aims to answer are: * How feasible and acceptable is the inter...

What is the current status of trial NCT05838027?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-04. Estimated completion is 2023-10-20.

What conditions does trial NCT05838027 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT05838027?

The interventions under investigation include: Cash Transfer (BEHAVIORAL).

Who is sponsoring clinical trial NCT05838027?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05838027 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05838027's enrollment target sits among peer trials

100 194th of 300 higher than 101 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05838027, the US trial registry maintained by the National Library of Medicine. NCT05838027 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.